semaglutide deaths 2024 flow trial kidney outcomes results Patients with type 2 #diabetes and chronic disease are flow trial semaglutide renal outcomes

What options exist heading into 2026

With the ability to monitor long-term outcomes, explore off-label use, and study real-world prescribing patterns, Truveta Data represents a transformative resource for advancing the future of GLP-1 research.

DOI: 10.1002/biof.5520190309

So many women who have tried to get pregnant in the past without success are finding suprise pregnancy to be one of the side effects of using a GLP-1

Ozempic (semaglutide) is a diabetes medication that often leads to weight loss as a secondary benefit

Position among weight-management supplements: L-carnitine may offer a small boost when an individual already has nutrition, sleep, and physical activity optimised